Annotated Medicine and Device Lists

Atropine

Injection 1 mg (sulfate) in 1-ml ampoule Injection 0.5 mg/mL Injection 250 mcg/mL Injection 500 mcg (sulfate)/mL Injection 2.5 mg (sulfate)/mL Injection 0.5 mg (sulphate) in 1-mL ampoule Solution (eye drops) 0.1% (sulfate) Solution (eye drops) 0.5% (sulfate) Solution (eye drops) 1% (sulfate) Solution (eye drops) 0.5-1% Solution (eye drops) 0.33% Solution (eye drops) 0.5% (sulfate) Solution (eye drops) 1% (sulfate)

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	1.3. Preoperative medication and sedation for short-term procedures	No observations
WHO Model List of Essential Medicines (2021)	4.2. Specific	No observations
Bolivia	LINAME 2011 - 2013	No observations
Peru	1.3 Pre-Operative and Sedative Medications for Short Procedures	No observations
Peru	4.2 Specifics	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	5.0 Cardiovascular	No observations
Training CSamouge 2022	1.3 Preoperative medication and sedation for short-term procedures	No observations
Training CSamouge 2022	4.2 Specific	No observations

This medicine is present in:

List	Section	Observation
Peru	4.2 Specifics	No observations
Cuba	1.3 Coadyuvantes de la anestesia, medicación preoperatoria y sedación para procedimientos de corto tiempo	No observations

This medicine is present in:

List	Section	Observation
Peru	17.4 Anti-Spasmodics	No observations

This medicine is present in:

List	Section	Observation
Peru	17.4 Anti-Spasmodics	No observations
Venezuela (incomplete)	List of Generic Medications - Venezuela	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Cuba	4.1 Específicos	No observations
Cuba	17.5 Antiespasmódicos	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	21.5. Mydriatics	Age or weight restriction: >3 months. Others observations: Therapeutic alternatives: - cyclopentolate hydrochloride - homatropine hydrobromide EMLc only

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	21.5. Mydriatics	Age or weight restriction: >3 months. Others observations: Therapeutic alternatives: - cyclopentolate hydrochloride - homatropine hydrobromide EMLc only
Chile	Essential and Prioritized Medications	No observations
Colombia	09.3.6 Mydriatics	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	21.5. Mydriatics	Age or weight restriction: >3 months. Others observations: Therapeutic alternatives: - cyclopentolate hydrochloride - homatropine hydrobromide EMLc only
Bolivia	LINAME 2011 - 2013	No observations
Peru	21.5 Mydriatics	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	09.3.6 Mydriatics	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Cuba	21.5 Midriáticos	No observations

This medicine is present in:

List	Section	Observation
Cuba	21.5 Midriáticos	No observations

Information Resources: Atropine

No information available